AI assistant
PFIZER INC — Director's Dealing 2011
Jul 5, 2011
29831_dirs_2011-07-05_41bb0f87-81ba-4030-b2f0-98d88cba5823.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2011-06-30
Reporting Person: LANKLER DOUGLAS M (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-06-30 | Common Stock | A | 48544.0000 | $0.0000 | Acquired | 137103.0000 | Direct |
| 2011-06-30 | Common Stock | F | 13452.0000 | $20.6000 | Disposed | 123651.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-06-30 | Phantom Stock Units SSP | $ | A | 96.0000 | Acquired | Common Stock (96.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1830.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F2: Represents withholding of shares to satisfy tax obligations upon vesting of restricted stock units.
F3: Each unit represents one phantom share of common stock.
F4: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.